James Huang - Net Worth and Insider Trading
James Huang Net Worth
The estimated net worth of James Huang is at least $1 Million dollars as of 2024-06-01. James Huang is the Director of CASI Pharmaceuticals Inc and owns about 371,708 shares of CASI Pharmaceuticals Inc (CASI) stock worth over $1 Million. James Huang is the Director of Windtree Therapeutics Inc and owns about 2,920 shares of Windtree Therapeutics Inc (WINT) stock worth over $10,426. James Huang is also the Director of Alaunos Therapeutics Inc and owns about 7,222 shares of Alaunos Therapeutics Inc (TCRT) stock worth over $7,872. Details can be seen in James Huang's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James Huang has not made any transactions after 2022-09-08 and currently still holds the listed stock(s).
Transaction Summary of James Huang
James Huang Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Huang owns 4 companies in total, including Alaunos Therapeutics Inc (TCRT) , CASI Pharmaceuticals Inc (CASI) , and Windtree Therapeutics Inc (WINT) among others .
Click here to see the complete history of James Huang’s form 4 insider trades.
Insider Ownership Summary of James Huang
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCRT | Alaunos Therapeutics Inc | 2022-06-22 | director |
| CASI | CASI Pharmaceuticals Inc | 2022-09-08 | director |
| WINT | Windtree Therapeutics Inc | 2023-02-22 | director |
 | | 2021-05-12 | director & Chief Executive Officer |
James Huang Latest Holdings Summary
James Huang currently owns a total of 3 stocks. Among these stocks, James Huang owns 371,708 shares of CASI Pharmaceuticals Inc (CASI) as of September 8, 2022, with a value of $1 Million and a weighting of 98.74%. James Huang owns 2,920 shares of Windtree Therapeutics Inc (WINT) as of October 19, 2021, with a value of $10,426 and a weighting of 0.72%. James Huang also owns 7,222 shares of Alaunos Therapeutics Inc (TCRT) as of September 1, 2021, with a value of $7,872 and a weighting of 0.54%.
Latest Holdings of James Huang
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CASI | CASI Pharmaceuticals Inc | 2022-09-08 | 371,708 | 3.87 | 1,438,510 |
| WINT | Windtree Therapeutics Inc | 2021-10-19 | 2,920 | 3.57 | 10,426 |
| TCRT | Alaunos Therapeutics Inc | 2021-09-01 | 7,222 | 1.09 | 7,872 |
Holding Weightings of James Huang
James Huang Form 4 Trading Tracker
According to the SEC Form 4 filings, James Huang has made a total of 4 transactions in CASI Pharmaceuticals Inc (CASI) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in CASI Pharmaceuticals Inc is the acquisition of 55,573 shares on September 8, 2022, which cost James Huang around $229,516.
According to the SEC Form 4 filings, James Huang has made a total of 11 transactions in Windtree Therapeutics Inc (WINT) over the past 5 years, including 11 buys and 0 sells. The most-recent trade in Windtree Therapeutics Inc is the acquisition of 56 shares on October 19, 2021, which cost James Huang around $95,000.
According to the SEC Form 4 filings, James Huang has made a total of 1 transactions in Alaunos Therapeutics Inc (TCRT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Alaunos Therapeutics Inc is the acquisition of 6,667 shares on September 1, 2021, which cost James Huang around $171,000.
Insider Trading History of James Huang
- 1
James Huang Trading Performance
GuruFocus tracks the stock performance after each of James Huang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Huang is -25.74%. GuruFocus also compares James Huang's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Huang within 3 months outperforms 1 times out of 16 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Huang's insider trading performs compared to the benchmark.
Performance of James Huang
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.92 | | | | | |
| Relative Return to S&P 500(%) | -7.1 | | | | | |
James Huang Ownership Network
James Huang Owned Company Details
What does Alaunos Therapeutics Inc do?
Who are the key executives at Alaunos Therapeutics Inc?
James Huang is the director of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .
Alaunos Therapeutics Inc (TCRT) Insider Trades Summary
Over the past 18 months, James Huang made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net sale of 68,014 shares made by Boyle Kevin S. Sr. ,
In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,534 shares of Alaunos Therapeutics Inc (TCRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,534 shares.
Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alaunos Therapeutics Inc Insider Transactions
James Huang Mailing Address
Above is the net worth, insider trading, and ownership report for James Huang. You might contact James Huang via mailing address: 9620 Medical Center Drive, Suite 300, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
